Who can use Vosevi(Sofosbuvir/Velpatasvir/Voxilaprevir)?

The specific patient populations and HCV genotypes for which VOSEVI is prescribed.

Approved Uses

VOSEVI is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults without cirrhosis or with compensated cirrhosis (Child-Pugh A). It is approved for patients with genotype 1, 2, 3, 4, 5, or 6 infection who were previously treated with a regimen containing an NS5A inhibitor. It is also indicated for patients with genotype 1a or 3 infection who were previously treated with a regimen containing sofosbuvir without an NS5A inhibitor.